Abstract:Pancreatic cancer is known to have a high mortality rate, and its early diagnosis remains challenging due to the occult location of the pancreas. Exosomes derived from pancreatic cancer cells specifically express glypican-1, which may provide a liquid biopsy opportunity for the early diagnosis of pancreatic cancer. Herein, an inductively coupled plasma mass spectrometry (ICP-MS) and photothermal dual-readout platform was proposed for the ultrasensitive and point-of-care analysis of pancreatic cancer exosomes. In our design, exosomes were specifically captured by the sandwich immunoassay, and simultaneously, alkaline phosphatase was introduced in a low-background manner. The alkaline phosphatase triggered the hydrolysis of l-ascorbic acid 2-phosphate to produce ascorbic acid, followed by the etching of Fe3O4@MnO2 nanoflowers. As a result, the Mn2+ generated by etching stripped off the Fe3O4 and was quantified using ICP-MS. Meanwhile, the reduced Fe3O4@MnO2 was applied for the photothermal assay by oxidizing dopamine with MnO2. The protocol exhibits a detection limit down to 19.1 particles mL–1, which is the most sensitive protocol reported so far. To our knowledge, this is the first endeavor for exosome quantification using ICP-MS and photothermal methods. The developed dual-readout platform not only is capable of distinguishing pancreatic cancer patients from healthy people, but also shows excellent discernibility of individual differences at low concentrations of exosomes. This dual-readout assay is a promising platform for the ultrasensitive and point-of-care detection of exosomes in liquid biopsy-based early cancer diagnosis.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.analchem.1c02004.Chemicals and materials; Cell culture and exosome isolation; Schematic illustration of preparing Fe3O4@MnO2 nanoflowers; Schematic illustration of ALP-induced etching of Fe3O4@MnO2 nanoflowers; Characterization of exosomes isolated by the ultracentrifugation and magnetic separation; UV–vis absorption spectra of polydopamine nanoparticles and dopamine; Optimization of experimental parameters; Table of operating parameters for ICP-MS detection of exosomes; and Table of comparison of the developed method with the reported methods for exosome quantification (PDF)This article has not yet been cited by other publications.

Proteomic Characterization of Urinary Exosomes with Pancreatic Cancer by Phosphatidylserine Imprinted Polymer Enrichment and Mass Spectrometry Analysis

Proteomic Discovery and Array-Based Validation of Biomarkers from Urinary Exosome by Supramolecular Probe

Elevated Expression of Exosomal Microrna-21 As a Potential Biomarker for the Early Diagnosis of Pancreatic Cancer Using a Tethered Cationic Lipoplex Nanoparticle Biochip.

Bilateral efforts to improve SERS detection efficiency of exosomes by Au/Na7PMo11O39 Combined with Phospholipid Epitope Imprinting

Ultrasensitive and Reversible Nanoplatform of Urinary Exosomes for Prostate Cancer Diagnosis.

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer

Highly Sensitive Exosome Detection for Early Diagnosis of Pancreatic Cancer Using Immunoassay Based on Hierarchical Surface‐Enhanced Raman Scattering Substrate

Quantification of GPC1(+) Exosomes Based on MALDI-TOF MS in Situ Signal Amplification for Pancreatic Cancer Discrimination and Evaluation.

ICP-MS and Photothermal Dual-Readout Assay for Ultrasensitive and Point-of-Care Detection of Pancreatic Cancer Exosomes

Serum Derived Exosomes from Pancreatic Cancer Patients Promoted Metastasis: an Itraq-Based Proteomic Analysis

Characterization of Exosomes in Plasma of Patients with Breast, Ovarian, Prostate, Hepatic, Gastric, Colon, and Pancreatic Cancers

Progress and potential of exosome analysis for early pancreatic cancer detection

Isolation and proteomic profiling of urinary exosomes from patients with colorectal cancer

Analysis of Differentially Expressed Proteome in Urinary Exosome from Non-small Cell Lung Cancer Patients

Exosomes: Navigating a New Route in Pancreatic Cancer

Urinary Exosomes: Potential Diagnostic Markers and Application in Bladder Cancer

Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

Exosomal proteins as prostate cancer biomarkers in urine: From mass spectrometry discovery to immunoassay-based validation

Proteomics-Based Identification of Candidate Exosomal Glycoprotein Biomarkers and Their Value for Diagnosing Colorectal Cancer

Pancreatic Cancer-Derived Exosomes Promote Tumor Metastasis and Liver Pre-Metastatic Niche Formation